Magnesium Sulfate and Prematurity etween 1959 and 1966, two Institutes of the National preventing cerebral palsy is unsettled, but the bulk of evidence Institutes of Health sponsored the National Collaborato this point weighs against it. tive Perinatal Study, a detailed observational study of Drs. Granier, Middelanis, Jensen, and Berger offer an interantenatal, natal, and neonatal events in about 54,000 pregnan-esting, technically demanding contribution of possible use in cies delivered at 12 American university hospitals. The intent this unclear picture. Using in vitro studies in adult guinea pig was to define determinants of fetal-neonatal brain injury. Cehippocampus sections exposed to decreased glucose availabilrebral palsy was chosen as the index variable because the ity, the authors demonstrate diminished adenosine triphosdiagnosis could be made objectively based on motor dysfuncphate and protein production as a result, both of which are tion by age 2 to 3 years in most cases. More than 45,000 partially reversed by perfusion with magnesium ion at three children were followed up to age 7 years, and 189 cases of times normal concentration given before, but not after, nutricerebral palsy were observed. In most cases, no factor in labor ent deprivation. The same oxygen glucose decrement resulted and delivery was a major predictor of brain injury, and the in increased guanosine triphosphate (GTP) activity, partially incidence of birth asphyxia was 9%.1.2 Birth weight less than reduced by increased magnesium ion perfused before but not 1.5 kg was an important risk factor in that and subsequent after nutrient deprivation. Increase in GTP in this system is studies.' Because electronic fetal monitoring was not then a prevented by N-nitro-L-arginine, a substance known to block regular part of prenatal and labor care, and other independent endothelial nitric oxide synthase activity. The authors' intervariables needed to be evaluated, a case-control study was pretation is that the salutary effects of magnesium in vitro are carried out using data from approximately 155,000 births beattributable to decreased nitric oxide production signaled by tween 1983 and 1985 in the San Francisco Bay area. That palsy in the 99 affected infants with birth weights less than 2 i f kg, whose mothers did not receive magnesium sulfate for Some reactions result in nitrate production, which ameliorates hypertensive disease but rather for tocolysis of preterm labor.5 effects of nitric oxide. Other reactions can lead to structural Teifrdhtbl palsy iand functional tissue changes. Unique among signaling mole-They inferred that the reduced nisk of cerebral palsy in pregnancies complicated by pregnancy hypertension might spuri-cules for its multiple and diverse roles, there can be either too ously have influenced the prior observation. A subsequent much or too little nitric oxide at reactive sites, with pathologic study designed to address this issue was halted prematurely by results ensuing in either case. It is not safe to constrict the role studỹ~~~~~~~~~o nitric oxid todes neuotxiit alone, even with cardiovascular a cluster of fetal and perinatal deaths.6 The suggested prenatal of nitric oxide to neurotoxicity alone, even with cardiovascular jeopardy was promptly refuted by analysis of newborns weigh-phenomena excluded. It is for these reasons that the authors list ing 1 kg or less where magnesium sulfate did not result in 11 references to magnesium's efficacy in preventing experiincreased infant mortality or morbidity. In this case the diag-mental brain injury, three of which were nonprotective and nosis of cerebral palsy was based on infant observations only up eight protective. Three additional studies showed increased to 4 months of age, and cerebral palsy was therefore possibly brain injury in vivo in experimental animals after magnesium underreported.7 A recent review of the role of magnesium ion use after fetal brain ischemia and prolonged nitric oxide sulfate in determining perinatal mortality, not cerebral palsy, inhibition.91 In this research neither the answers, the quesinvolving a review of 14,876 neonatal intensive care unit tions, nor the data interpretations are clear. Hopefully, further admissions showed the adjusted crude mortality rates to be work will resolve these issues and questions. reduced significantly in magnesium-treated pregnancies compared with controls.8 The data allow a firm conclusion that Thomas H. Kirschbaum, MD neonatal death is not increased by magnesium sulfate and a less Department of Obstetrics/Gynecology, robust conclusion that it is also of no benefit in preventing Division of Maternal-Fetal Medicine, death. Lacking a large prospective controlled randomized trial, University of Alabama Birmingham College of Medicine, it is fair to say that the clinical utility of magnesium sulfate in Birmingham, Alabama
